High-efficacy therapy discontinuation vs continuation in patients 50 years and older with nonactive MS

G Jouvenot, G Courbon, M Lefort, F Rollot… - JAMA …, 2024 - jamanetwork.com
Importance A recent randomized clinical trial concluded that discontinuing medium-efficacy
therapy might be a reasonable option for older patients with nonactive multiple sclerosis …

Analyzing Interval-Censored Recurrence Event Data with Adjusting Informative Observation Times by Propensity Scores

N Li, M Lin, Y Shang - Mathematics, 2024 - mdpi.com
In this paper, we discuss the statistical inference of interval-censored recurrence event data
under an informative observation process. We establish an additive semiparametric mean …